About Gino Santini
Gino Santini is a director at Alzheon.
Gino Santini reports to the SEC as a director or officer of 8 public companies, including Collegium Pharmaceutical (COLL), COMPASS Pathways plc (CMPS) and Intercept Pharmaceuticals (ICPT).
Gino Santini first appears on SEC filings in 2006.
Experience
This experience comes from Gino Santini's profile and from SEC filings. For roles taken from filings, the years are when the filings name Gino Santini in the role, so the role may have started earlier or lasted longer.
LG
Lakefront Biotherapeutics (former Galapagos) Current
Chair of the Board of Directors
2026 – Present
Alzheon, Inc. Current
Director
2024 – Present · Framingham, MA
Develops investigational medicines for people with Alzheimer’s and other neurodegenerative disorders.
CP
COMPASS Pathways plc Current
Chairman of the Board
2024 – Present · Public company (CMPS)
AL
Alfasigma Current
Board Member
2024 – Present
CI
Collegium Pharmaceutical, Inc. Current
Chairman of the Board
2012 – Present · Public company (COLL)
II
Intercept Pharmaceuticals, Inc.
Director
2015 – 2023 · Public company (ICPT)
HC
Horizon Therapeutics Public Ltd Co
Director
2012 – 2023 · Public company (HZNP)
HP
Horizon Pharma
Board member
2012 – 2023
AI
Allena Pharmaceuticals, Inc.
Director
2012 – 2022 · Public company (ALNA)
AI
Amag Pharmaceuticals, Inc.
Chairman of the Board
2012 – 2020 · Public company (AMAG)
IT
Intarcia Therapeutics
Board Member
2013 – 2020
VI
Vitae Pharmaceuticals, Inc
Director
2014 – 2016 · Public company (VTAE)
SG
Sorin Group
Board Member
2012 – 2015
FI
Finanziaria Saccarifera Italo Iberica
Board Member
2013 – 2014
EC
Eli Lilly & Co.
Sr.VP, Corp. Strategy & BD
2006 – 2010 · Public company (LLY)
EC
Eli Lilly and Company
Senior VP Corporate Strategy & Business Development
1990 – 2010
Key Colleagues at Startups
The people Gino Santini works with at each company, as listed on that company's latest Form D.
Alzheon, Inc. · Form D, Sep 10, 2026
Christopher Dunn
Director
Neil Flanzraich
Executive Chairman of the Board of Directors
Diane Jorkasky, M.D.
Director
JD
John Hey, Ph.D.
Chief Scientific Officer
SD
Susan Abushakra, M.D.
Chief Medical Officer
MS
Muneer Satter
Director
Jordan Heller
Director
AM
Aidan Power, MRCPsych
Chief Development Officer
Kenneth Mace
Chief Financial Officer
MD
Martin Tolar, M.D., Ph.D.
Founder, President & CEO, director
Adem Albayrak
Chief Data & AI Officer